On the contrary, there was also previous report indicating that CD133 was expressed in well-differentiated gastric cancers and not poorly-differentiated gastric cancers, although CD133-positive gastric cancers had significantly worse prognosis [25]. This evidence concerns the gene PROM1 and gastric cancer.